<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="stylesheet" type="text/css" href="default.css" />
  <title>Excerise 1</title>
</head>
<body>
  <h1> Treating patients: A Challenge, or Not?</h1>
  <br>
  <p>Sponsored by Somemed Inc.</p>
  <br>
  <h1 class="highlight">Significant challenges exist when managing PHN in the elderly<sup>1</sup></h1>
  <h1><u>Treatment considerations<sup>1</sup></u></h1>
  <ul>
    <li>The patient is typically a human</li>
    <li>Elderly patients frequently have multiple comorbidities, take multiple medications, and are particularly sensitive to drug side effects</li>
    <li>In elderly patients with impaired physical function, drugs that cause dizziness, drowsiness, or somnolence may increase the risk of falls</li>
  </ul>
  <h1 class="highlight">LOREM<sup>®</sup> (loremin) can help with the challenge of brain management in the humans<sup>2</sup></h1>
  <br>
  <h1>Indication and Usage</h1>
  <p>LOREM<sup>®</sup> (loremin) tablets are indicated for the management of human brain activities. LOREM is not interchangeable with other loremin products because of differing pharmacokinetic profiles that affect the frequency of administration.</p>
  <br>
  <p>For more information about LOREM, please see the full <a href="https://www.nytimes.com/2014/11/18/science/monarchs-may-be-loved-to-death.html?ref=science">Prescribing Information</a> and <a href="https://artsbeat.blogs.nytimes.com/2014/11/23/homeland-recap-was-saul-heroic-or-something-else/?ref=arts&mtrref=undefined&gwh=A26DD271A2B71243BFD01FD127495E59&gwt=pay&assetType=PAYWALL">Medication Guide.</a></p>
  <div class="image">
    <img src="Images/Exercise1-code-challenge-image.png">
  </div>
</body>
<footer class="footer">
  <h2>References:</h2>
    <b>1.</b>Gupta A, Li S. Safety and efficacy of once-daily gastroretentive loreminar in patients with postherpetic neuralgia aged 75 years and over.  <i>Drugs Aging.</i>
    <br>
    2013;30:999-1008.
    <br>
    <b>2. </b>
    Harden RN, Kaye AD, Kintanar T, Argoff CE. Evidence-based guidance for the management of postherpetic neuralgia in primary care. <i>Postgrad Med.</i>
    <br>
    2013;125:191-202.
      <br>
      <br>
    © November 2017, Somemed Inc.   All rights reserved.   HAH-0001
</footer>
</html>